Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Sorrento Therapeutics Inc (NASDAQ:SRNE) Reports Positive Results From Phase 1b Clinical…
Celsion Corporation (NASDAQ:CLSN) Presents A Poster Highlighting Its Phase I And…
Synthetic Biologics Inc (NYSE:SYN) begins Phase 1a Clinical Trial Of SYN-020…
Gritstone Oncology Inc (NASDAQ:GRTS) Begins Phase 1 Clinical Study Of COVID-19…
Timber Pharmaceuticals Inc (NYSE:TMBR) Receives ODD For TMB-003 From The US…
Finance
Hollywall Entertainment Inc (OTCMKTS:HWAL): Under-the-Radar NFT Star in the Making? (PLBY,…
GeoVax Labs (GOVX) surges on positive sentiment
Compass Pathways (CMPS) could lead psychedelic sector
Moderna Inc (NASDAQ:MRNA) Signs Deal With Baxter International Inc (NYSE:BAX) For…
Bitcoin Stocks for the Win (SQ, RIOT, ISWH, HVBTF)
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:FOLD
Tag: NASDAQ:FOLD
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Reports Topline Results Of AT-GAA In Phase...
Ward Sport
-
February 22, 2021
0
Amicus Therapeutics (NASDAQ:FOLD) Commences Rolling BLA For AT-GAA In Treatment Of...
Gavins Felicity
-
December 11, 2020
0
Amicus Therapeutics Inc. (NASDAQ:FOLD) Reports Q3 2020 Financial Results With Galafold...
Kate Hudson
-
November 13, 2020
0
Amicus Therapeutics (NASDAQ:FOLD) Announce Encouraging Preliminary AT-GTX-501 Gene Therapy Results In...
Gavins Felicity
-
October 28, 2020
0
Amicus Therapeutics (NASDAQ:FOLD) Granted PRIME Designation By European Medicines Agency For...
Ward Sport
-
September 30, 2020
0
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Posts Revenues Of $62.4 Million In Q2...
Gavins Felicity
-
August 26, 2020
0
.td-post-views{ display: none !important; }
